Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-08-07 Sale | 2026-08-11 5:08 pm | Dianthus Therapeutics Inc. | DNTH | Veness Adam M SVP, General Counsel and Sec. | 20,000 | $110.44 | $2,208,833 | 136,167 (Direct) | View |
| 2026-06-17 Sale | 2026-06-18 4:30 pm | Dianthus Therapeutics Inc. | DNTH | Veness Adam M SVP, General Counsel and Sec. | 30,000 | $80.8 | $2,423,958 | 80,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-08-13 Exercise | 2026-08-14 4:30 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Veness Adam M SVP, General Counsel and Sec. | 15,000 | $18.17 | 88,240 (Direct) | View |
| 2026-08-13 Exercise | 2026-08-14 4:30 pm | N/A 2033-06-28 | Dianthus Therapeutics Inc. | DNTH | Veness Adam M SVP, General Counsel and Sec. | 15,000 | $0 | 88,240 (Direct) | View |
| 2026-08-07 Exercise | 2026-08-11 5:08 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Veness Adam M SVP, General Counsel and Sec. | 20,000 | $17.88 | 136,167 (Direct) | View |
| 2026-08-07 Exercise | 2026-08-11 5:08 pm | N/A 2034-01-23 | Dianthus Therapeutics Inc. | DNTH | Veness Adam M SVP, General Counsel and Sec. | 20,000 | $0 | 136,167 (Direct) | View |
| 2026-06-17 Exercise | 2026-06-18 4:30 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Veness Adam M SVP, General Counsel and Sec. | 30,000 | $17.88 | 80,000 (Direct) | View |
| 2026-06-17 Exercise | 2026-06-18 4:30 pm | N/A 2034-01-23 | Dianthus Therapeutics Inc. | DNTH | Veness Adam M SVP, General Counsel and Sec. | 30,000 | $0 | 80,000 (Direct) | View |
| 2026-02-03 Option Award | 2026-02-04 5:41 pm | N/A 2036-02-03 | Dianthus Therapeutics Inc. | DNTH | Veness Adam M SVP, General Counsel and Sec. | 100,000 | $0 | 100,000 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-04 4:23 pm | N/A 2035-02-02 | Dianthus Therapeutics Inc. | DNTH | Veness Adam M SVP, General Counsel and Sec. | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-28 8:05 pm | N/A 2034-05-22 | Dianthus Therapeutics Inc. | DNTH | Veness Adam M SVP, General Counsel and Sec. | 75,000 | $0 | 75,000 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 4:46 pm | N/A 2034-01-23 | Dianthus Therapeutics Inc. | DNTH | Veness Adam M SVP, General Counsel and Sec. | 110,000 | $0 | 110,000 (Direct) | View |
Ownership | 2023-09-13 8:48 pm | N/A 2033-06-28 | Dianthus Therapeutics Inc. | DNTH | Veness Adam M See Remarks | 0 | $0 | 88,240 (Direct) | View |
| 2023-02-03 Option Award | 2023-02-07 4:14 pm | N/A 2033-02-03 | Cyteir Therapeutics Inc. | CYT | Veness Adam M General Counsel | 96,100 | $0 | 96,100 (Direct) | View |
| 2022-05-02 Option Award | 2022-05-04 4:22 pm | N/A 2032-04-25 | Cyteir Therapeutics Inc. | CYT | Veness Adam M General Counsel | 177,000 | $0 | 177,000 (Direct) | View |
| 2021-11-19 Equity Swap | 2021-11-22 09:05 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 23,423 | $0 | 0 (Direct) | View |
| 2021-11-09 Exercise | 2021-11-12 4:15 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 4,500 | $29.37 | 23,423 (Direct) | View |
| 2021-11-09 Exercise | 2021-11-12 4:15 pm | N/A 2024-08-01 | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 4,500 | $0 | 23,423 (Direct) | View |